Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists”

Carl Samuelsen, Eric D. Bateman, Ian Pavord, Adam Lloyd, Mike Baldwin and Dirk Esser ()
Additional contact information
Carl Samuelsen: Boehringer Ingelheim
Eric D. Bateman: University of Cape Town
Ian Pavord: University of Oxford
Adam Lloyd: IMS Health
Mike Baldwin: Boehringer Ingelheim
Dirk Esser: Boehringer Ingelheim

Applied Health Economics and Health Policy, 2016, vol. 14, issue 1, No 11, 117-118

Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40258-015-0215-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:aphecp:v:14:y:2016:i:1:d:10.1007_s40258-015-0215-0

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40258

DOI: 10.1007/s40258-015-0215-0

Access Statistics for this article

Applied Health Economics and Health Policy is currently edited by Timothy Wrightson

More articles in Applied Health Economics and Health Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().